Saturday 17 October 2026
Export CNMD’s income statement to Excel — free account
CONMED Corporation
CNMD Healthcare Medical Devices
CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 11.6%, free cash flow grew 46.0% and total debt fell 5.40%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
46.72
0.42
−0.89%
Follow CNMD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
26.89 | 15.95 | 52.19 | 0.00 | 66.24 | 339.39 | 109.64 | 43.97 | 25.43 | 84.98 |
Piotroski F-Score |
5 | 8 | 7 | 2 | 8 | 5 | 4 | 6 | 6 | 4 |
P/S ratio |
0.92 | 1.62 | 2.71 | 2.58 | 4.09 | 3.71 | 3.32 | 2.10 | 1.78 | 1.61 |
Altman Z-Score |
1.86 | 2.32 | 2.52 | 1.99 | 3.88 | 2.94 | 2.98 | 2.99 | 2.51 | 2.28 |
Altman Z″-Score (non-manufacturers) |
2.97 | 3.16 | 2.46 | 2.11 | 3.15 | 2.59 | 2.64 | 3.46 | 3.20 | 3.07 |
P/FCF ratio |
8.35 | 13.72 | 31.77 | 232.82 | 42.66 | 62.14 | 42.20 | 31.02 | 26.82 | 48.90 |
Beneish M-Score |
(2.70) | (2.55) | (2.37) | (2.69) | (2.57) | (2.68) | (2.67) | (2.51) | (2.42) | (2.53) |
P/Operating CF |
27.19 | 48.71 | 59.89 | (232.46) | 122.36 | 158.90 | 77.49 | 73.08 | 67.94 | 89.73 |
Dividend Safety Score |
63 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.22 | 2.19 | 4.05 | 3.62 | 5.26 | 4.51 | 4.46 | 2.73 | 2.24 | 2.12 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.49 | 2.29 | 3.48 | 3.56 | 4.75 | 4.55 | 4.09 | 2.61 | 2.35 | 2.23 |
EV/EBITDA |
11.25 | 10.77 | 21.79 | 25.76 | 24.68 | 29.74 | 23.96 | 16.86 | 17.71 | 18.28 |
EV/Operating CF |
12.03 | 17.92 | 34.52 | 111.55 | 42.93 | 60.86 | 41.11 | 30.05 | 28.49 | 42.62 |
EV/FCF |
13.61 | 19.45 | 40.70 | 321.41 | 49.51 | 76.23 | 52.09 | 38.57 | 35.43 | 67.64 |
Quick Ratio |
0.92 | 0.94 | 0.86 | 0.74 | 1.04 | 1.08 | 1.14 | 1.24 | 1.33 | 1.54 |
Current Ratio |
2.14 | 2.30 | 1.98 | 1.96 | 2.34 | 2.19 | 2.11 | 2.33 | 2.38 | 2.90 |
Net Debt/EBITDA |
4.35 | 3.17 | 4.78 | 7.10 | 3.41 | 5.50 | 4.55 | 3.30 | 4.30 | 5.07 |
Debt/Assets |
35.90% | 39.28% | 42.34% | 45.91% | 38.77% | 43.02% | 43.31% | 33.37% | 35.82% | 37.51% |
Debt/Equity |
0.81 | 0.94 | 1.17 | 1.41 | 0.87 | 1.06 | 1.08 | 0.69 | 0.77 | 0.86 |
Asset Turnover |
0.59 | 0.57 | 0.54 | 0.51 | 0.57 | 0.49 | 0.61 | 0.63 | 0.59 | 0.63 |
Operating CF/Net income |
3.63 | 1.26 | 1.94 | (0.41) | 1.79 | 6.78 | 3.32 | 1.83 | 1.18 | 2.72 |
Capex/Depreciation |
(0.25) | (0.17) | (0.24) | (0.29) | (0.18) | (0.15) | (0.24) | (0.27) | (0.22) | (0.27) |
Interest Coverage |
3.30 | 5.37 | 3.03 | 2.42 | 3.09 | 1.04 | 1.85 | 3.45 | 2.58 | 2.45 |
| 4.72% | 14.74% | 8.16% | (10.53%) | 8.37% | 1.34% | 4.17% | 6.32% | 9.16% | 2.52% | |
| 2.03% | 5.75% | 2.80% | (3.97%) | 3.56% | 0.54% | 1.82% | 3.00% | 4.13% | 1.21% | |
ROIC |
3.51% | 6.79% | 4.23% | 2.47% | 4.73% | 2.00% | 3.40% | 4.05% | 2.70% | 2.24% |
Return on Tangible Assets |
9.99% | 27.72% | 15.14% | (20.13%) | 16.80% | 2.82% | 8.72% | 12.51% | 17.18% | 4.33% |
Average Days of Receivables |
65.80 | 66.39 | 71.04 | 66.80 | 66.41 | 74.97 | 72.27 | 77.09 | 76.56 | 70.87 |
Research and Development Expense of Revenue |
4.07% | 4.16% | 4.23% | 4.51% | 4.31% | 4.69% | 4.76% | 4.91% | 4.06% | 4.22% |
Selling, General and Administrative Expense of Revenue |
43.06% | 36.59% | 40.41% | 43.43% | 41.04% | 43.34% | 41.90% | 41.37% | 44.17% | 44.32% |
Intangible Assets out of Total Assets |
0.60 | 0.62 | 0.63 | 0.65 | 0.62 | 0.64 | 0.65 | 0.59 | 0.60 | 0.61 |
Share Based Compensation of Revenue |
2.06% | 1.96% | 1.95% | 2.08% | 1.62% | 1.52% | 1.23% | 1.17% | 1.06% | 1.10% |
Graham Net Nets |
(0.49) | (0.33) | (0.25) | (0.36) | (0.13) | (0.20) | (0.21) | (0.18) | (0.26) | (0.34) |
Graham Number |
33.63 | 54.89 | 35.94 | 0.00 | 36.01 | 13.57 | 23.99 | 27.82 | 31.81 | 15.63 |
Earnings Yield |
3.72% | 6.27% | 1.92% | (3.08%) | 1.51% | 0.29% | 0.91% | 2.27% | 3.93% | 1.18% |
Free Cash Flow Yield |
11.97% | 7.29% | 3.15% | 0.43% | 2.34% | 1.61% | 2.37% | 3.22% | 3.73% | 2.05% |
Revenue per Share |
44.29 | 42.37 | 40.59 | 34.80 | 34.66 | 30.18 | 33.72 | 30.57 | 28.50 | 27.46 |
Operating CF per Share |
5.50 | 5.41 | 4.09 | 1.11 | 3.83 | 2.26 | 3.36 | 2.66 | 2.35 | 1.43 |
Capex per Share |
(0.64) | (0.42) | (0.62) | (0.73) | (0.51) | (0.46) | (0.71) | (0.59) | (0.46) | (0.53) |
Free Cash Flow per Share |
4.86 | 4.99 | 3.47 | 0.39 | 3.32 | 1.80 | 2.65 | 2.07 | 1.89 | 0.90 |
Cash per Share |
1.32 | 0.79 | 0.79 | 0.96 | 0.71 | 0.96 | 0.91 | 0.62 | 1.17 | 0.99 |
Shareholders Equity per Share |
33.29 | 31.21 | 27.20 | 24.82 | 26.93 | 24.81 | 25.08 | 23.55 | 22.60 | 20.88 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
33.29 | 31.21 | 27.20 | 24.82 | 26.93 | 24.81 | 25.08 | 23.55 | 22.60 | 20.88 |
Free Cash Flow |
150.88 | 153.88 | 106.32 | 11.58 | 96.90 | 51.52 | 75.07 | 58.19 | 52.72 | 25.13 |
Working Capital |
357.82 | 361.88 | 304.92 | 284.67 | 263.48 | 226.45 | 209.28 | 213.41 | 206.78 | 216.56 |
Capital Expenditures |
(19.81) | (13.08) | (19.03) | (21.78) | (14.87) | (13.01) | (20.07) | (16.51) | (12.84) | (14.75) |
Net Current Asset Value |
(619.79) | (703.56) | (850.15) | (970.82) | (520.46) | (625.98) | (667.26) | (332.52) | (369.75) | (417.89) |
EV/EBIT |
20.02 | 14.94 | 35.88 | 53.13 | 43.73 | 85.36 | 49.43 | 31.48 | 39.80 | 45.11 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Price to Operating Income |
12.28 | 10.54 | 28.00 | 38.49 | 37.68 | 69.57 | 40.04 | 25.32 | 30.13 | 32.61 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.71 | 0.67 | 0.65 | 0.64 | 0.78 | 0.77 | 0.71 | 0.55 | 0.50 | 0.45 |
Cash ROIC |
7.90% | 8.13% | 5.80% | 0.63% | 6.50% | 3.46% | 4.99% | 5.12% | 4.58% | 2.27% |
Accounts Receivable Turnover |
5.66 | 5.45 | 5.74 | 5.57 | 5.60 | 4.71 | 5.15 | 4.93 | 5.05 | 5.41 |
Accounts Payable Turnover |
6.37 | 6.03 | 7.04 | 7.21 | 7.94 | 7.36 | 7.86 | 8.17 | 8.73 | 9.30 |
Inventory Turnover |
1.78 | 1.73 | 1.75 | 1.68 | 2.08 | 2.24 | 2.70 | 2.64 | 2.64 | 2.64 |
Average Days of Payables |
54.76 | 65.02 | 56.64 | 56.49 | 47.99 | 48.38 | 47.47 | 50.00 | 42.00 | 42.80 |
Days of Inventory on Hand |
207.89 | 220.48 | 204.38 | 255.78 | 191.03 | 176.86 | 139.61 | 144.49 | 141.30 | 139.62 |
Average Receivables |
242.78 | 240.01 | 216.81 | 187.61 | 180.52 | 183.12 | 185.32 | 174.29 | 157.64 | 141.05 |
Average Payables |
97.95 | 95.24 | 80.81 | 65.80 | 55.75 | 54.64 | 54.73 | 47.77 | 41.85 | 38.18 |
Average Inventory |
351.13 | 332.52 | 325.32 | 281.98 | 213.26 | 179.74 | 159.61 | 148.02 | 138.65 | 134.62 |
Average Assets |
2,316.00 | 2,303.13 | 2,298.81 | 2,031.80 | 1,758.85 | 1,763.38 | 1,572.12 | 1,363.55 | 1,343.47 | 1,215.34 |
Average Common Equity |
997.89 | 898.45 | 789.88 | 765.49 | 747.24 | 709.75 | 686.37 | 646.85 | 606.00 | 582.82 |
Columns are period end dates